細胞株の詳細データ
TKG 0163 :: MM46
ID | TKG 0163 | ||||||||||||||||||||
Cell name | MM46 | ||||||||||||||||||||
Data accepted | |||||||||||||||||||||
Animal | Mouse (C3H/He) | ||||||||||||||||||||
Scientific name | Mus musculus. | ||||||||||||||||||||
Sex | |||||||||||||||||||||
Case history | sp. | ||||||||||||||||||||
Tissue | Mammary cancer. | ||||||||||||||||||||
Genetics | mode=69 | ||||||||||||||||||||
Life span | Infinite. | ||||||||||||||||||||
Morphology | |||||||||||||||||||||
Medium | RPMI-1640 + 10% FBS + 2ME. | ||||||||||||||||||||
Passage method | Dilution. | ||||||||||||||||||||
Characteristics | This tissue culture cell line was established from a cell line maintained by in vivo transplantation. Conditions for transplantation, ip:100:15-20 (transplantation site : transplantation rate : survival days), MM antigen (+++). | ||||||||||||||||||||
Temperature | 37℃ | ||||||||||||||||||||
CO2 concentration | 5% | ||||||||||||||||||||
Subculture frequency | |||||||||||||||||||||
Classification | |||||||||||||||||||||
Mycoplasma | PCR: -, Hoechst DNA staining : ± | ||||||||||||||||||||
Isozyme analysis | NP | ||||||||||||||||||||
Established by | Tachibana, T. | ||||||||||||||||||||
References | Int. J. Cancer, 4, 121-129, 1969(PMID: 4899787)., Int. J. Cancer, 4, 130-138, 1969(PMID: 5347282)., Int. J. Cancer, 4, 139-149, 1969(PMID: 5347283)., Int. J. Cancer, 4, 150-158, 1969(PMID: 5347284)., Int. J. Cancer, 6, 304-313, 1970(PMID: 5479440)., Gann, 66, 489-497, 1975(PMID: 1082827)., J. Immunol., 31, 201-205, 1982. Tohoku J. Exp. Med., 152, 67-80, 1987(PMID: 3617061). Appendix: origin of MM46, MM47 and MM48 tumor cell lines. As documented
in cancer Research 31, 1682-1689, 1971(PMID: 4330634), Dr. Irie established SMCXX III (MM48), and SMCXX V (MM47) ascitic tumor
cell lines in Research Institute for Medical Science, Tokyo University.
After her moving to UCLA, Dr. Tachibana succeeded passaging both cell lines
and also solid tumor cell line SMCXX VI. At 26th passage, at 604 days,
he succeeded in converting the solid tumor to ascitic form and named it
as MM46. The names of tumor cell lines were designated by Dr. Tachibana.
Table 7 in the above paper should be rewritten as follow.
No. in parenthesis, transplant generations or days required for ascitic conversion. |
||||||||||||||||||||
References by users | Cancer Chemother. Pharmacol., 43, 247-256, 1999(PMID: 9923556), Mol Cell Biol. 2019 Aug 12;39(17):e00154-19(PMID: 31208979). | ||||||||||||||||||||
Comments | |||||||||||||||||||||
Deposited by | |||||||||||||||||||||
Restriction | |||||||||||||||||||||
Photo |